Herpes:
Symptoms, Outbreaks, and Treatment

HSV-1 and HSV-2 explained. Symptoms, outbreak triggers, antiviral treatment, and managing herpes long-term.

HSV-1 vs HSV-2

HSV-1 (Oral Herpes) — Cold sore on the lip.

HSV-2 (Genital Herpes) — Clustered vesicular lesions. Image: Wikimedia Commons (CC BY-SA).

Herpes simplex virus comes in two forms: HSV-1 and HSV-2. HSV-1 has traditionally been associated with oral herpes (cold sores around the mouth), while HSV-2 has been linked primarily to genital herpes. However, either type can infect either location. HSV-1 is increasingly recognized as a common cause of genital herpes, often transmitted through oral-genital contact.

HSV-1 is extremely prevalent, affecting an estimated 3.7 billion people under age 50 worldwide according to the World Health Organization. HSV-2 affects approximately 491 million people ages 15 to 49 globally. Both types establish lifelong latent infection in nerve ganglia, meaning the virus remains in the body permanently even when no symptoms are present.

From a clinical standpoint, the distinction between HSV-1 and HSV-2 matters primarily for prognosis. Genital HSV-2 tends to recur more frequently than genital HSV-1, with an average of four to six outbreaks per year in the first year compared to roughly one recurrence per year for genital HSV-1. Your provider can help determine which type you have through type-specific serologic testing and recommend a management plan accordingly.

First Outbreak Symptoms

Cold Sore Stages: What to Expect

Stage	What Happens	Timeline	Clinical Photo
Stage 1 Prodrome	Tingling, itching, or burning sensation. Skin appears normal. Not everyone experiences this.	Day 1–2
Stage 2 Redness	Skin becomes red and swollen. No blister yet. May itch or feel tender.	Day 2–3
Stage 3 Blisters	Small fluid-filled blisters form. Clear at first, turn yellow. Most contagious stage.	Day 3–4
Stage 4 Ulcer	Blisters rupture into shallow open sores. Sore and painful. Highly contagious.	Day 4–5
Stage 5 Crusting	A flaky crust or scab develops. May crack and bleed. Healing underway.	Day 5–8
Stage 6 Healing	Crust flakes off with new skin underneath. Some residual redness.	Day 8–12
Stage 7 Healed	Skin entirely back to normal. Virus remains dormant until next outbreak.	Day 12–14

Clinical photos: BMJ Open (Open Access, CC BY 4.0).

Note: Antiviral medications like valacyclovir are most effective when started during Stage 1 (prodrome) or Stage 2 (redness), before blisters form.

The first herpes outbreak, known as the primary episode, is typically the most severe. It usually occurs within 2 to 12 days after exposure, though some individuals may not develop symptoms for weeks or even months. The initial outbreak often begins with prodromal symptoms such as tingling, itching, or burning in the affected area, followed by the appearance of clustered small blisters on an erythematous base.

Common symptoms of a primary herpes outbreak include:

• Clusters of painful, fluid-filled blisters on or around the genitals, rectum, or mouth
• Blisters that rupture and form shallow, painful ulcers that crust over and heal within 2 to 4 weeks
• Painful urination, especially if lesions are near the urethra
• Flu-like symptoms including fever, body aches, headache, and swollen lymph nodes
• Vaginal or urethral discharge

The primary outbreak can last two to four weeks and may be accompanied by significant discomfort. It is important to note that many people with herpes have mild or unrecognized first episodes, which is one reason the virus spreads so readily. If you are experiencing any of these symptoms, a telehealth herpes evaluation can help you get a diagnosis and begin treatment promptly.

Recurrent Outbreaks

After the primary episode resolves, the herpes virus retreats into the sensory nerve ganglia where it remains dormant. Periodically, the virus reactivates and travels back along the nerve to the skin surface, causing recurrent outbreaks. Recurrences are generally shorter and less severe than the initial episode, typically lasting 3 to 7 days. Many patients notice a prodromal phase of tingling, burning, or itching at the site 12 to 24 hours before lesions appear.

Recurrence frequency varies widely. Genital HSV-2 recurs more often than genital HSV-1, with the first year after diagnosis typically having the highest number of outbreaks. Over time, most people experience fewer and milder recurrences as the immune system develops a stronger response to the virus.

Several factors are known to trigger recurrent outbreaks:

• Physical or emotional stress
• Illness, fatigue, or a weakened immune system
• Sun exposure or UV light (particularly for oral herpes)
• Hormonal changes such as menstruation
• Friction or trauma to the affected area
• Surgery or immunosuppressive medications

How Herpes Spreads

Herpes spreads through direct skin-to-skin contact with an infected area, most commonly during oral, vaginal, or anal sexual activity. The virus can be transmitted when visible sores are present, but it can also spread during periods of asymptomatic viral shedding, when the virus is active on the skin surface without causing noticeable symptoms. Studies suggest that a significant proportion of herpes transmissions occur during these asymptomatic periods.

HSV-1 is frequently transmitted through non-sexual contact such as kissing or sharing utensils, particularly during childhood. Genital HSV-1 infection often results from receiving oral sex from a partner with oral herpes. HSV-2 is transmitted almost exclusively through sexual contact.

Key points about transmission risk:

• Condoms reduce but do not eliminate transmission risk, as the virus can shed from areas not covered by a condom
• Asymptomatic shedding is more frequent with HSV-2 than HSV-1
• Transmission risk is highest during active outbreaks
• Daily suppressive antiviral therapy can reduce the risk of transmitting genital herpes to a partner by approximately 50 percent
• Herpes is not spread through toilet seats, swimming pools, or casual surface contact

Antiviral Treatment

Antiviral medications are the cornerstone of herpes treatment. While they do not cure the infection, they can significantly shorten outbreak duration, reduce symptom severity, and lower the risk of transmission to partners. The three FDA-approved antivirals for herpes are acyclovir, valacyclovir (Valtrex), and famciclovir (Famvir). Valacyclovir is the most commonly prescribed due to its convenient dosing schedule and excellent oral bioavailability.

For a primary outbreak, antiviral therapy is typically prescribed for 7 to 10 days. Episodic treatment for recurrent outbreaks involves a shorter course, usually 1 to 5 days depending on the medication used. Treatment is most effective when started within 72 hours of symptom onset, ideally during the prodromal phase before blisters fully develop.

Common episodic treatment regimens include:

• Valacyclovir 500 mg twice daily for 3 days, or 1 g once daily for 5 days
• Acyclovir 800 mg three times daily for 2 days, or 400 mg three times daily for 5 days
• Famciclovir 1,000 mg twice daily for 1 day, or 125 mg twice daily for 5 days

Through a telehealth herpes consultation, your provider can prescribe the appropriate antiviral regimen based on your outbreak history and individual needs.

Suppressive Therapy

Suppressive therapy involves taking an antiviral medication daily on an ongoing basis rather than only during outbreaks. This approach is recommended for patients who experience frequent recurrences (typically six or more per year) or who want to reduce the risk of transmitting herpes to a sexual partner. Daily suppressive therapy with valacyclovir has been shown to reduce outbreak frequency by 70 to 80 percent and decrease the risk of sexual transmission by approximately 50 percent.

The most common suppressive regimens include:

• Valacyclovir 500 mg once daily (for patients with fewer than 10 outbreaks per year) or 1 g once daily
• Acyclovir 400 mg twice daily
• Famciclovir 250 mg twice daily

Long-term suppressive therapy is considered safe and well-tolerated. Studies spanning several years have not identified significant adverse effects from continuous use. Many patients remain on suppressive therapy for years, though providers may periodically reassess whether continued daily dosing is necessary, as outbreak frequency naturally decreases over time for most individuals.

Living With Herpes

A herpes diagnosis can feel overwhelming, but it is important to understand that herpes is an extremely common and manageable condition. Millions of people live normal, healthy lives with herpes, including fulfilling sexual relationships. The emotional impact of a diagnosis often outweighs the physical symptoms, and addressing the psychological component is an important part of care.

Practical strategies for managing herpes long-term include:

• Communicating openly with sexual partners about your diagnosis before intimate contact
• Using condoms consistently to reduce (though not eliminate) transmission risk
• Discussing suppressive therapy with your provider if you are in a serodiscordant relationship
• Managing stress through regular exercise, adequate sleep, and relaxation techniques
• Avoiding known personal triggers such as excessive sun exposure or fatigue
• Keeping antiviral medication on hand so you can begin episodic treatment at the first sign of a recurrence

Having herpes does not define your health or your relationships. With proper management and open communication, the impact on daily life is minimal for most people. If you are struggling with the emotional aspects of a diagnosis, consider speaking with a counselor or joining a support community.

Getting Treatment Online

Telehealth is well-suited for herpes management because diagnosis and treatment decisions are often based on symptom history and clinical presentation rather than in-person examination. Many patients prefer the privacy and convenience of a virtual visit when discussing sensitive sexual health concerns. Through a telehealth appointment, a provider can evaluate your symptoms, discuss your outbreak history, and prescribe antiviral medications the same day.

At InnoCre Telehealth, our board-certified providers offer confidential herpes treatment consultations for patients in Maryland, Washington, and Delaware. During your visit, your provider can:

• Assess your symptoms and discuss whether testing is appropriate
• Prescribe episodic antiviral treatment for active outbreaks
• Evaluate whether daily suppressive therapy is right for you
• Order type-specific HSV blood tests through a local laboratory if needed
• Address questions about transmission risk and partner notification

If you suspect you have herpes or need ongoing management of a known diagnosis, schedule a same-day telehealth visit to get started. We also provide comprehensive STD testing and treatment services for patients who want to screen for multiple infections.

Frequently Asked Questions